300970 华绿生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.081-3.1301.9855.3251.362
总资产报酬率 ROA (%)0.701-2.1501.4814.0581.020
投入资产回报率 ROIC (%)0.781-2.4101.6444.4121.116

边际利润分析
销售毛利率 (%)8.9405.95913.52216.3206.657
营业利润率 (%)1.953-4.2712.72710.7672.943
息税前利润/营业总收入 (%)2.585-3.5212.6619.3761.143
净利润/营业总收入 (%)1.941-4.3042.64710.3332.816

收益指标分析
经营活动净收益/利润总额(%)55.97791.021140.93885.12913.344
价值变动净收益/利润总额(%)0.000-0.1961.3905.25413.424
营业外收支净额/利润总额(%)-0.5410.434-3.021-1.175-1.349

偿债能力分析
流动比率 (X)3.9142.6062.6863.8375.351
速动比率 (X)2.7821.7251.8812.9874.724
资产负债率 (%)33.92734.09826.00523.11823.390
带息债务/全部投入资本 (%)15.35815.00310.08813.94014.557
股东权益/带息债务 (%)469.283482.281814.013599.162564.466
股东权益/负债合计 (%)191.390189.795280.865329.901325.557
利息保障倍数 (X)4.024-4.577193.875-7.407-0.649

营运能力分析
应收账款周转天数 (天)5.5926.1715.62811.83316.340
存货周转天数 (天)68.86971.26472.14175.84363.962